CompletedPhase 2

SB208 for the Treatment of Tinea Pedis

Dominican Republic222 participantsStarted 2016-07-19

Plain-language summary

This is a phase 2, multi-center, double-blind, randomized, vehicle-controlled study to be conducted in non immunocompromised adult subjects with interdigital tinea pedis.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Otherwise healthy male and female subjects with clinical diagnosis of interdigital t. pedis * T.pedis provisionally confirmed at baseline by a positive KOH wet mount for segmented fungal hyphae on skin scraping from the target site Exclusion Criteria: * Women who are pregnant or nursing or planning on becoming pregnant * Subjects with onychomycosis or moccasin-type t. pedis * Subjects using topical or systemic anti-fungal agents

What they're measuring

Fungal culture result

Timeframe: 2 weeks

Trial details

NCT IDNCT02860052

SponsorNovan, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2017-01

View on ClinicalTrials.gov More Tinea Pedis trials